文献速递关节外科

关节置换患者报告结局绩效测量合规性的替代抽样策略建议

A Proposed Alternative Sampling Strategy for Centers for Medicare & Medicaid Services Arthroplasty Patient-Reported Outcome Performance Measure Compliance.
PubMed 文献 · J Arthroplasty · 2026-06-10

美国CMS要求关节置换医院报告髋/膝关节置换患者报告结局,需匹配术前术后量表覆盖≥50.0%合格患者。本研究计算了不同年手术量医院达到95%CI宽度10.0%(±5.0%)所需的最小样本量,发现随机抽样策略在高手术量医院所需样本远少于CMS按比例规则。

要点

  • CMS现行规则要求匹配术前术后PROM覆盖≥50.0%合格患者,可能对低手术量医院产生不可靠估计。
  • 随机抽样策略在年手术量5000例医院仅需357例,而CMS规则需2500例。
  • 随机抽样尤其可减轻年手术量≥500例医院的报告负担,此类医院约占年THA/TKA总量的35.0%。

核心结论

  • 现行CMS报告规则可能对低手术量医院产生不可靠的绩效估计,同时给高手术量医院带来过度报告负担和潜在偏倚。
  • 随机抽样策略可提供更精确有效的估计,并显著减轻医院负担,尤其是年THA/TKA≥500例的医院。

研究设计与样本

  • 本研究为方法学分析,计算年THA/TKA手术量为5、50、500和5000例的医院,在假定达到实质性临床获益率为50.0%时,获得95%CI宽度10.0%(±5.0%)所需完成的最小PROM数量。
  • 将计算结果与现行CMS要求进行比较,并进行敏感性分析探讨CI宽度、医院手术量和实质性临床获益达到频率对所需样本量的影响。

主要发现

  • CMS按手术量比例规则要求年手术量5、50、500和5000例的医院分别需要3、25、250和2500例患者。
  • 基于统计学的随机抽样策略分别需要5、45、218和357例患者。
  • 敏感性分析证实随机抽样可减少高手术量医院所需的样本量。

关键数值与推荐

  • CMS现行要求:匹配的术前和术后PROM覆盖≥50.0%的所有合格患者,不考虑医院手术量。
  • 目标估计精度:95%CI宽度10.0%(±5.0%),假定实质性临床获益达到率为50.0%。
  • 年手术量5、50、500、5000例的医院,CMS规则所需样本分别为3、25、250、2500例,随机抽样所需样本分别为5、45、218、357例。

临床怎么用

  • 对于年THA/TKA≥500例的医院,可考虑采用随机抽样策略替代CMS按比例规则,以降低报告负担并可能获得更精确的绩效估计。
  • 低手术量医院应注意CMS现行规则可能导致绩效估计不可靠,需谨慎解读绩效结果。

局限性

  • 本研究为基于假设的统计学计算,未涉及实际实施随机抽样的可行性和成本。
  • 分析基于实质性临床获益达到率为50.0%的保守假设,实际达到率不同可能影响所需样本量。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The Centers for Medicare & Medicaid Services (CMS) mandates reporting of Hip Disability and Osteoarthritis Outcome Score for Joint Replacement and Knee Injury and Osteoarthritis Outcome Score for Joint Replacement to support a hospital-level patient-reported outcome performance measure. The current CMS requires matched preoperative and postoperative patient-reported outcome measures for ≥ 50.0% of all eligible patients, regardless of hospital volume. This may yield unreliable performance estimates for low-volume centers and potentially biased and unnecessarily large estimates for large hospitals. The purpose of this study was to determine the smallest sample required to produce statistically valid patient-reported outcome performance measure estimates. METHODS: We calculated the minimum number of completed patient-reported outcome measures needed in order to achieve a 95% confidence interval width 10.0% (± 5.0%) for hospitals with five, 50, 500, and 5,000 eligible total hip arthroplasty (THA) and total knee arthroplasty (TKA) cases annually, assuming a conservative substantial clinical benefit achievement of 50.0%. These values were compared with current CMS requirements. Sensitivity analyses explored the effects of confidence interval width, hospital volume, and frequency of substantial clinical benefit attainment on required sample sizes. RESULTS: The CMS's volume-proportional rule requires three, 25, 250, and 2,500 patients for hospitals with five, 50, 500, and 5,000 annual cases, respectively. In contrast, a statistically grounded random sampling strategy would require five, 45, 218, and 357 patients, respectively. Sensitivity analyses confirmed that random sampling reduces required sample sizes for high-volume hospitals. CONCLUSIONS: The current CMS reporting rule may produce unreliable performance estimates for low-volume hospitals while imposing excessive reporting burdens and potentially biased results for high-volume hospitals. A random sampling strategy may provide more precise and valid estimates while substantially reducing hospital burden, especially among the hospitals performing 500 or more THA and TKAs per year, which comprise approximately 35.0% of all THAs and TKAs annually.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Lyman S, Chin AS, Alschuler DM, et al. A Proposed Alternative Sampling Strategy for Centers for Medicare & Medicaid Services Arthroplasty Patient-Reported Outcome Performance Measure Compliance. J Arthroplasty. 2026. PMID: 42269953. doi:10.1016/j.arth.2026.06.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。